07:42 AM EDT, 07/18/2024 (MT Newswires) -- GoodRx Holdings ( GDRX ) has partnered with Boehringer Ingelheim to provide discounts for Boehringer's biosimilar to Abbvie's ( ABBV ) rheumatoid arthritis drug Humira, the companies said Thursday.

Boehringer's Adalimumab-adbm is a citrate-free, injectable medication approved by the US Food and Drug Administration as an interchangeable biosimilar to Humira, the companies said.

The drug may be purchased at a discount on GoodRx ( GDRX ) by anyone with a valid prescription, regardless of insurance status, they added.